Home/Filings/4/0001610717-24-000059
4//SEC Filing

Ruiz Briseno Andres 4

Accession 0001610717-24-000059

CIK 0001676725other

Filed

Feb 12, 7:00 PM ET

Accepted

Feb 13, 4:59 PM ET

Size

5.3 KB

Accession

0001610717-24-000059

Insider Transaction Report

Form 4
Period: 2024-02-09
Transactions
  • Sale

    Common Stock

    2024-02-09$46.02/sh2,000$92,04524,531 total
Footnotes (2)
  • [F1]The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 30, 2023.
  • [F2]This transaction was executed in multiple trades in prices ranging from $46.00 to $46.09, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Documents

1 file

Issuer

IDEAYA Biosciences, Inc.

CIK 0001676725

Entity typeother

Related Parties

1
  • filerCIK 0001983118

Filing Metadata

Form type
4
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 4:59 PM ET
Size
5.3 KB